A Phase III Multi-center, Open-label, Sponsor-blinded, Randomized Study of AZD0901 Monotherapy Compared with Investigator's Choice of Therapy in Second- or Later-Line Adult Participants with Advanced/Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

15423D9802C00001-NCT06346392OpenA Phase III Multi-center, Open-label, Sponsor-blinded, Randomized Study of AZD0901 Monotherapy Compared with Investigator's Choice of Therapy in Second- or Later-Line Adult Participants with Advanced/Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2D9802C00001NCT06346392IndustrialAdultTreatmentIIIOtherNoel, MarcusGeorgetown University Medical Center : Susan Lawrence; Lombardi Comprehensive Cancer Center : Susan LawrenceGastrointestinalOncology GroupLombardi Comprehensive Cancer Center (LCCC); Oncology PFS17105Susan LawrenceSusan Lawrencesl2328@georgetown.edu2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>